Citius Pharmaceuticals Inc.
CTXR | NASDAQ
$0.58
$0 (+0.61%)
Sep 22, 2026, 12:41 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 29, 2025 | FY 2024 Sep 29, 2024 | FY 2023 Sep 29, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 4.25M | 3.25M | 26.48M | 41.71M | 70.07M | 13.86M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 44.92M | n/a | 29.18M | 16.92M |
Other Long-Term Assets | 38.06K | 38.06K | -44.88M | 39.97M | 38.06K | 57.09K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 22.29M | 8.27M | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 27.93M | 14.22M | 34.37M | 44.56M | 72.81M | 13.98M |
Property-Plant & Equipment | 818.69K | 246.25K | 455.86K | 650.17K | 829.85K | 987.78K |
Goodwill & Intangibles | 102.15M | 102.15M | 68.75M | 68.75M | 68.75M | 28.75M |
Total Long-Term Assets | 103M | 102.43M | 69.24M | 69.44M | 69.61M | 29.79M |
Total Assets | 130.94M | 116.65M | 103.61M | 114M | 142.43M | 43.77M |
Account Payables | 13.69M | 4.93M | 2.93M | 1.17M | 1.28M | 1.86M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1M | 241.55K | 218.38K | 196.99K | 177.24K | 172.97K |
Other Current Liabilities | 3.29M | -241.55K | -218.38K | 1.57M | 1.73M | 1.65M |
Total Current Liabilities | 44.91M | 35.81M | 5.78M | 4.53M | 3.98M | 4.1M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 164.58K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 8.5M | 6.74M | 6.4M | 6.04M | 5.66M | 6.01M |
Total Liabilities | 53.41M | 42.55M | 12.18M | 10.57M | 9.65M | 10.1M |
Total Debt | 1.81M | 262.87K | 481.25K | 678.23K | 855.47K | 1.35M |
Book Value | 77.53M | 74.1M | 91.43M | 103.43M | 132.78M | 33.67M |
Book Value Per Share | 7.01 | 6.39 | 9.06 | 10.62 | 18.34 | 12.90 |
Common Stock | 18.07K | 7.25K | 158.86K | 146.21K | 145.98K | 55.58K |
Retained Earnings | -238.8M | -201.37M | -162.23M | -129.69M | -96.05M | -70.59M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 67.55M | 70.08M | 90.83M | 102.83M | 132.18M | 33.67M |
Total Investments | n/a | n/a | 44.92M | n/a | 29.18M | 16.92M |
Add to Watchlist
Select watchlists to add or remove CTXR